The Nigeria Academy of Pharmacy has urged the government to prioritize health security through increased investment in pharmaceutical research and local drug production. Uchechukwu Nnaike, a key figure in the academy, emphasized the need for technological innovation to reduce the country’s reliance on imported medicines.

Nigeria currently imports a significant portion of its pharmaceutical needs, making it vulnerable to supply chain disruptions and price fluctuations. The academy argues that strengthening local production capabilities will improve access to essential medicines and ensure a more stable healthcare system. Nnaike highlighted that investing in research and innovation could also create jobs and boost the economy.

This call comes amid growing concerns about the country’s ability to respond to public health crises, such as the ongoing challenges with malaria and the potential for future pandemics. The academy’s recommendations align with global trends toward self-sufficiency in critical medical supplies. While no immediate policy changes have been announced, the discussion reflects a broader push for national health resilience.